Acute Myocardial Infarction (AMI) Successfully Treated With Stentys Self-expanding Platform, Solving Stent-malapposition

Medical News Today
16th March 2009




Medical device pioneer Stentys announced that it has extended its 'self-expanding' and 'disconnectable' technology platform to include a second major indication-acute myocardial infarction (AMI). Two patients were successfully treated during acute myocardial infarction procedures last week by Drs. S. Verheye (Antwerp, Belgium) and K. E. Hauptmann (Trier, Germany).

The versatile Stentys platform has two features- self-expansion and disconnectability-that are designed to be unrivaled in the stent industry. The self-expanding feature insures optimal apposition in the critical initial hours and days after the procedure by being constantly applied to the vessel surface during thrombus and vessel spasm relief, therefore avoiding malapposition, a significant concern to cardiologists. The disconnectability feature is designed to treat lesions close to a bifurcation, by ensuring safe main branch provisional stenting and optimal side branch access when needed. Equally important, the Stentys platform is implanted by usual stenting techniques requiring no additional training.